Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.48 |
| ▸ | MMP9 | P14780 | 1/20 | 0.47 |
| ▸ | MMP8 | P22894 | 1/20 | 0.47 |
| ▸ | MMP14 | P50281 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | RECQL | P46063 | 1/20 | 0.43 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.43 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.43 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | NOD1 | Q9Y239 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | ACHE | P22303 | 5/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7803945 | 0.92 | DPP7 (0.51) | DPP7GNAI3GNAO1GNAI1NOD1 | |
| SCHEMBL7797320 | 0.91 | GNAI3 (0.50) | DPP7GNAI3GNAO1GNAI1NOD1 | |
| SCHEMBL7797290 | 0.91 | GNAI3 (0.50) | DPP7GNAI3GNAO1GNAI1NOD1 | |
| SCHEMBL982585 | 0.86 | CYP3A4 (0.57) | MMP9MMP8MMP14CYP3A4TSHR | |
| SCHEMBL9702525 | 0.85 | CYP3A4 (0.58) | MMP9MMP8MMP14CYP3A4TSHR | |
| SCHEMBL457464 | 0.82 | ACHE (0.57) | DPP7GNAI3GNAO1GNAI1ACHE | |
| SCHEMBL7534573 | 0.82 | ACHE (0.57) | DPP7GNAI3GNAO1GNAI1ACHE | |
| SCHEMBL10724285 | 0.82 | ACHE (0.55) | MMP9MMP8MMP14CYP3A4TSHR | |
| SCHEMBL23608137 | 0.81 | ACHE (0.53) | DPP7GNAI3GNAO1GNAI1NOD1 | |
| SCHEMBL23607693 | 0.81 | ACHE (0.53) | DPP7GNAI3GNAO1GNAI1NOD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20010055620-A1 | New lysine derivatives containing an Ne-alkoxy or Ne-alkenoxycarbonyl group, their preparation and their use in cosmetic, pharmaceutical, hygiene or food compositions | L'OREAL | 2001-12-27 | — | — | US | claimed |
| EP-0652209-B1 | Derivatives of N-epsilon alkoxy-or alkenoxy-carbonyl lysine, their preparation and use in cosmetic, pharmaceutical, hygiene or alimentary compositions | OREAL (FR) | 1998-04-08 | — | — | EP | claimed |
| US-20010055620-A1 | New lysine derivatives containing an Ne-alkoxy or Ne-alkenoxycarbonyl group, their preparation and their use in cosmetic, pharmaceutical, hygiene or food compositions | L'OREAL | 2001-12-27 | — | — | US | disclosed |
| US-6207173-B1 | Lysine derivatives containing an Nε-alkoxy or Nε-alkenoxycarbonyl group, their preparation and their use in cosmetic, pharmaceutical, hygiene or food compositions | L'OREAL (FR) | 2001-03-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010055620-A1 | New lysine derivatives containing an Ne-alkoxy or Ne-alkenoxycarbonyl group, their preparation and their use in cosmetic, pharmaceutical, hygiene or food compositions | DOT1L, KDM7A, JMJD6 | DPP7 2135/4885MMP9 1852/4885MMP8 874/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.